Home›People›James Wilkie
JW

James Wilkie

Founder & CEO, director at Platform Therapeutics.

ExecutiveDirector
Updated Nov 9, 2026·Latest SEC filing Aug 27, 2026·Suggest an edit

About James Wilkie

James Wilkie is a founder & CEO, director at Platform Therapeutics.

Experience

This experience comes from James Wilkie's profile and from SEC filings. For roles taken from filings, the years are when the filings name James Wilkie in the role, so the role may have started earlier or lasted longer.

Platform Therapeutics, Inc. Current
Founder & CEO, director
2022 – Present · Andover, MA
Develops treatments for patients affected by chemotherapy toxicity and dialysis-related muscle cramps.
PneumoNIX Medical Current
CEO
2022 – Present
Lowell Therapeutics, Inc.
CEO
2018 – 2022
La Jolla Pharmaceutical Company
VP, New Enterprise Development
2014 – 2018
Pluromed, Inc.
Chief Operating Officer
2005 – 2012
CONMED Corporation
Manager
2004 – 2005
Surgical Sealants, Inc.
President & CEO
1997 – 2003
MedChem Products
Director of Engineering
1993 – 1997
CR Bard
Engineer, Project Engineer, Senior Project Engineer
1987 – 1993
North American Philips
Engineer
1985 – 1987

Key Colleagues at Startups

The people James Wilkie works with at each company, as listed on that company's latest Form D.

Platform Therapeutics, Inc. · Form D, Aug 27, 2026
LC
Lakhmir Chawla
Founder, Chairman, & CMO

Sources

  1. SECPlatform Therapeutics, Inc. Form D, filed Aug 27, 2026